14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $43.33 $52.87 Friday, 3rd May 2024 BMY stock ended at $43.99. This is 0.664% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 1.48% from a day low at $43.69 to a day high of $44.33.
90 days $43.33 $55.03
52 weeks $43.33 $69.10

Historical Bristol-Myers Squibb Company prices

Date Open High Low Close Volume
Feb 04, 2016 $59.62 $60.75 $59.19 $59.70 7 876 000
Feb 03, 2016 $59.20 $60.18 $57.94 $60.12 11 112 800
Feb 02, 2016 $60.03 $60.30 $58.46 $58.87 9 856 500
Feb 01, 2016 $61.87 $62.36 $60.05 $60.82 10 183 500
Jan 29, 2016 $61.65 $62.64 $61.16 $62.16 10 060 500
Jan 28, 2016 $64.17 $64.25 $60.00 $61.16 16 999 600
Jan 27, 2016 $62.94 $62.95 $61.16 $61.71 7 439 600
Jan 26, 2016 $63.03 $63.05 $61.92 $62.69 5 526 200
Jan 25, 2016 $64.23 $64.42 $62.64 $62.92 7 928 500
Jan 22, 2016 $64.46 $64.80 $63.65 $64.40 6 633 600
Jan 21, 2016 $63.94 $63.97 $62.50 $63.13 5 665 200
Jan 20, 2016 $62.24 $64.58 $61.80 $63.55 8 678 400
Jan 19, 2016 $63.61 $64.43 $62.56 $63.21 8 461 300
Jan 15, 2016 $61.69 $62.92 $61.07 $62.78 11 230 600
Jan 14, 2016 $61.32 $63.91 $60.89 $63.51 9 343 600
Jan 13, 2016 $63.60 $64.48 $61.19 $61.28 9 706 400
Jan 12, 2016 $63.25 $63.79 $62.12 $63.44 7 796 200
Jan 11, 2016 $63.71 $63.99 $61.98 $62.98 10 337 800
Jan 08, 2016 $65.60 $65.79 $63.50 $63.63 9 076 400
Jan 07, 2016 $65.85 $66.69 $64.95 $65.29 8 436 600
Jan 06, 2016 $67.47 $68.27 $66.85 $67.15 6 691 400
Jan 05, 2016 $67.50 $68.90 $67.42 $68.35 7 836 700
Click to get the best stock tips daily for free!

About Bristol-Myers Squibb Company

Bristol-Myers Squibb Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; Eliquis, an oral inhibitor for reduction in risk of stroke/systemic embolism in NVAF, and for th... BMY Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT